Objectives: The aim of this study was to compare the eradication of Helicobacter pylori in dyspeptic patients is four quadruple regimen.
Design and Methods: In this prospective, randomized, open-label study , 270 patients with positive rapid urease test were randomly divided into four treatment groups.
Inclusion and exclusion criteria: Patients with positive rapid urease test that their chronic gastritis and Infection with Helicobacter pylori confirmed with histology were entered and Persons under 18 years of age at the time of endoscopy, those in the last month or bismuth compounds contain any antibiotics for any illness received., Pregnant and lactating women, people with serious diseases such as congestive heart failure, end-stage renal failure , cirrhosis and psychosis, patients with active gastrointestinal bleeding (upper), previous use of H. pylori eradication regimen and any favism patients were excluded from the study.
Interventions: Group A: Treatment with omeprazole + amoxicillin + clarithromycin + bismuth subcitrate for two weeks (73 patients)
Group B: Treatment with omeprazole + tetracycline + bismuth subcitrate + metronidazole for two weeks (46 patients
Group C: Treatment with omeprazole + amoxicillin + furazolidone + bismuth subcitrate for two weeks (64 patients
Group D: The first week: omeprazole + amoxycillin + bismuth subcitrate + Furazolidone then the second week: omeprazole + amoxicillin + bismuth subcitrate + metronidazole (87 patients).
The main outcome variables: Six weeks after stopping treatment, eradication rate, acceptance rate, and side effects were determined in each group.